Olmesartan Medoxomil and Diabetic Nephropathy - Test2 - elhamkhani - TriplyDB

Olmesartan Medoxomil and Diabetic Nephropathy

Olmesartan Medoxomil and Diabetic Nephropathy

http://www.wikidata.org/entity/Q61934759

about

Olmesartan Medoxomil and Diabetic Nephropathy

http://www.wikidata.org/entity/Q61934759

description

clinical trial

@en

klinisch onderzoek

@nl

name

Olmesartan Medoxomil and Diabetic Nephropathy

@en

type

label

Olmesartan Medoxomil and Diabetic Nephropathy

@en

prefLabel

Olmesartan Medoxomil and Diabetic Nephropathy

@en

P1050

Q61934759-1517A173-901A-4C35-B3BB-A8AFD77665DB

Q61934759-7FD49AAE-064C-4774-87D9-ADEE6BCEBB62

P1132

Q61934759-165E0EE7-8352-41E1-8462-E67295197801

P1476

Q61934759-E6FE87E0-E1B2-4B12-B86F-A5F592B0F3B6

P17

Q61934759-2EC9F4A8-4597-4003-992C-741CB5671796

Q61934759-3A911BFB-B7C3-48E8-B8C3-B537DF4CB382

Q61934759-7F463984-817C-4249-8F3C-16556CAB39FE

Q61934759-81B48757-EA36-4037-AD87-D7ACCFBA1806

Q61934759-CFB756F6-2EE4-45CD-90E5-12B599104476

Q61934759-DFE2C315-6D89-4090-B7BC-B47A4450EB2A

Q61934759-E4E3B7CE-DB2C-4421-A971-CC0ACFB771D7

P2899

Q61934759-61A21B96-0431-4375-8554-5650DB4224E4

P3098

Q61934759-D8AAE113-3878-44D4-A759-674CB79C4934

P31

Q61934759-46731A49-5F7E-48F4-B391-6079242D6C97

P4844

Q61934759-5EBE4C22-55E8-4F53-9716-679526C30048

Q61934759-88D74CB2-D535-41B2-B4CD-9C5EB742D122

Q61934759-B71C712C-6533-48CF-9709-D5375A0FAE5B

P580

Q61934759-3FFC5DA8-5FA9-4884-A6AE-F32C917D33F0

P6099

Q61934759-195E8BCC-E68F-421C-A353-BF029841070B

P8005

Q61934759-1CE1DB1A-0162-411F-BA0F-A1AA40022229

P1050

P1132

300

http://www.w3.org/2001/XMLSchema#decimal

P1476

Effect of Different Doses of O ...... e 2 Diabetics With Nephropathy

@en

P17

P2899

30

http://www.w3.org/2001/XMLSchema#decimal

P3098

NCT00362960

http://www.w3.org/2001/XMLSchema#string

P31

P4844

olmesartan medoxomil

P580

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6099

phase III clinical trial

P8005